| Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015 | 512 | 2015 |
| High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development D Lin, AW Wyatt, H Xue, Y Wang, X Dong, A Haegert, R Wu, S Brahmbhatt, ... Cancer research 74 (4), 1272-1283, 2014 | 395 | 2014 |
| Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer AW Wyatt, AA Azad, SV Volik, M Annala, K Beja, B McConeghy, ... JAMA oncology 2 (12), 1598-1606, 2016 | 356 | 2016 |
| Germline CDH1 deletions in hereditary diffuse gastric cancer families C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ... Human molecular genetics 18 (9), 1545-1555, 2009 | 257 | 2009 |
| The placental gene PEG10 promotes progression of neuroendocrine prostate cancer S Akamatsu, AW Wyatt, D Lin, S Lysakowski, F Zhang, S Kim, C Tse, ... Cell reports 12 (6), 922-936, 2015 | 255 | 2015 |
| From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer AV Lapuk, C Wu, AW Wyatt, A McPherson, BJ McConeghy, S Brahmbhatt, ... The Journal of pathology 227 (3), 286-297, 2012 | 213 | 2012 |
| BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma R Shrestha, N Nabavi, YY Lin, F Mo, S Anderson, S Volik, HH Adomat, ... Genome medicine 11, 1-12, 2019 | 102 | 2019 |
| Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ... Genome biology 15, 1-14, 2014 | 94 | 2014 |
| Novel lignin-capped silver nanoparticles against multidrug-resistant bacteria YN Slavin, K Ivanova, J Hoyo, I Perelshtein, G Owen, A Haegert, YY Lin, ... ACS applied materials & interfaces 13 (19), 22098-22109, 2021 | 83 | 2021 |
| Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer C Wu, AW Wyatt, AV Lapuk, A McPherson, BJ McConeghy, RH Bell, ... The Journal of pathology 227 (1), 53-61, 2012 | 81 | 2012 |
| Stromal gene expression is predictive for metastatic primary prostate cancer F Mo, D Lin, M Takhar, VR Ramnarine, X Dong, RH Bell, SV Volik, ... European urology 73 (4), 524-532, 2018 | 73 | 2018 |
| Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles M Yu, D Zloty, B Cowan, J Shapiro, A Haegert, RH Bell, L Warshawski, ... Journal of investigative dermatology 128 (7), 1797-1805, 2008 | 71 | 2008 |
| Performance assessment under field conditions of a rapid immunological test for transgenic soybeans J Fagan, B Schoel, A Haegert, J Moore, J Beeby International journal of food science & technology 36 (4), 357-367, 2001 | 63 | 2001 |
| SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA C Kockan, F Hach, I Sarrafi, RH Bell, B McConeghy, K Beja, A Haegert, ... Bioinformatics 33 (1), 26-34, 2017 | 59 | 2017 |
| Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer D Lin, X Dong, K Wang, AW Wyatt, F Crea, H Xue, Y Wang, R Wu, RH Bell, ... Oncotarget 6 (3), 1806, 2015 | 58 | 2015 |
| Heterochromatin protein 1α mediates development and aggressiveness of neuroendocrine prostate cancer X Ci, J Hao, X Dong, SY Choi, H Xue, R Wu, S Qu, PW Gout, F Zhang, ... Cancer research 78 (10), 2691-2704, 2018 | 54 | 2018 |
| Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target CC Collins, SV Volik, AV Lapuk, Y Wang, PW Gout, C Wu, H Xue, ... Molecular cancer therapeutics 11 (3), 775-783, 2012 | 52 | 2012 |
| miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer N Nabavi, NRN Saidy, E Venalainen, A Haegert, A Parolia, H Xue, ... Scientific reports 7 (1), 4079, 2017 | 51 | 2017 |
| Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies W Jäger, H Xue, T Hayashi, C Janssen, S Awrey, AW Wyatt, S Anderson, ... Oncotarget 6 (25), 21522, 2015 | 46 | 2015 |
| The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells MP Labrecque, MK Takhar, R Nason, S Santacruz, KJ Tam, S Massah, ... Oncotarget 7 (17), 24284, 2016 | 37 | 2016 |
